466 related articles for article (PubMed ID: 14502651)
1. Anatamopathological spectrum of tauopathies.
Revesz T; Holton JL
Mov Disord; 2003 Sep; 18 Suppl 6():S13-20. PubMed ID: 14502651
[TBL] [Abstract][Full Text] [Related]
2. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
Goedert M
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
[TBL] [Abstract][Full Text] [Related]
3. Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings.
Lees AJ
Mov Disord; 2003 Sep; 18 Suppl 6():S28-33. PubMed ID: 14502653
[TBL] [Abstract][Full Text] [Related]
4. The neuropathological spectrum of neurodegenerative tauopathies.
Tolnay M; Probst A
IUBMB Life; 2003 Jun; 55(6):299-305. PubMed ID: 12938731
[TBL] [Abstract][Full Text] [Related]
5. [Frontotemporal dementia: tau mutations, deposition, and molecular mechanisms of neuronal cell death].
Hasegawa M
Rinsho Shinkeigaku; 2004 Nov; 44(11):879-81. PubMed ID: 15651320
[TBL] [Abstract][Full Text] [Related]
6. Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau.
Williams DR
Intern Med J; 2006 Oct; 36(10):652-60. PubMed ID: 16958643
[TBL] [Abstract][Full Text] [Related]
7. Exon 3 insert of tau protein in neurodegenerative diseases.
Terada S; Ishizu H; Ishiguro K; Tanabe Y; Itoh N; Yasutake K; Furubayashi A; Kitamura Y; Kuroda S
Acta Neuropathol; 2005 Jul; 110(1):12-8. PubMed ID: 15918074
[TBL] [Abstract][Full Text] [Related]
8. Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies.
Ferrer I; Hernández I; Boada M; Llorente A; Rey MJ; Cardozo A; Ezquerra M; Puig B
Acta Neuropathol; 2003 Nov; 106(5):419-35. PubMed ID: 12955398
[TBL] [Abstract][Full Text] [Related]
9. [Japanese contribution to the understanding of frontotemporal dementia and parkinsonism linked to chromosome 17(FTDP-17)].
Tsuboi Y; Wszolek ZK; Mizuno Y; Kobayashi T; Yasuda M; Yamada T
No To Shinkei; 2003 Feb; 55(2):107-19. PubMed ID: 12684990
[TBL] [Abstract][Full Text] [Related]
10. Frontotemporal dementia with tau pathology.
Gasparini L; Terni B; Spillantini MG
Neurodegener Dis; 2007; 4(2-3):236-53. PubMed ID: 17596718
[TBL] [Abstract][Full Text] [Related]
11. [Neuropathology of tauopathies and synucleinopathies, and neuroanatomy of sleep disorders: meeting the challenge].
Hauw JJ; Hausser-Hauw C; Duyckaerts C
Rev Neurol (Paris); 2003 Nov; 159(11 Suppl):6S59-70. PubMed ID: 14646802
[TBL] [Abstract][Full Text] [Related]
12. Interface between tauopathies and synucleinopathies: a tale of two proteins.
Galpern WR; Lang AE
Ann Neurol; 2006 Mar; 59(3):449-58. PubMed ID: 16489609
[TBL] [Abstract][Full Text] [Related]
13. Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):658-64. PubMed ID: 12410387
[TBL] [Abstract][Full Text] [Related]
14. Transgenic zebrafish as a novel animal model to study tauopathies and other neurodegenerative disorders in vivo.
Paquet D; Schmid B; Haass C
Neurodegener Dis; 2010; 7(1-3):99-102. PubMed ID: 20173336
[TBL] [Abstract][Full Text] [Related]
15. Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein.
Feuillette S; Miguel L; Frébourg T; Campion D; Lecourtois M
J Neurochem; 2010 May; 113(4):895-903. PubMed ID: 20193038
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
Chalmers KA; Love S
J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
[TBL] [Abstract][Full Text] [Related]
17. [Clinical, genetic and pathological aspects of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)].
Tsuboi Y
Rinsho Shinkeigaku; 2004 Nov; 44(11):875-8. PubMed ID: 15651319
[TBL] [Abstract][Full Text] [Related]
18. Corticobasal degeneration: selected developments.
Lang AE
Mov Disord; 2003 Sep; 18 Suppl 6():S51-6. PubMed ID: 14502656
[TBL] [Abstract][Full Text] [Related]
19. Neurodegenerative tauopathies.
Lee VM; Goedert M; Trojanowski JQ
Annu Rev Neurosci; 2001; 24():1121-59. PubMed ID: 11520930
[TBL] [Abstract][Full Text] [Related]
20. Pick's complex and FTDP-17.
Kertesz A
Mov Disord; 2003 Sep; 18 Suppl 6():S57-62. PubMed ID: 14502657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
